Get the Stockscreener App
18.96
0.05%
-0.0267
Overview
News
Price History
Option Chain
Financials
Why KVUE Down?
Discussions
Forecast
Dividend History
Kenvue Inc stock is traded at $18.96, with a volume of 899.74K.
It is down -0.05% in the last 24 hours and down -0.47% over the past month.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
See More
Previous Close:
$18.93
Open:
$18.97
24h Volume:
899.74K
Relative Volume:
0.05
Market Cap:
$36.43B
Revenue:
$15.29B
Net Income/Loss:
$1.62B
P/E Ratio:
22.48
EPS:
0.8433
Net Cash Flow:
$1.82B
1W Performance:
-1.46%
1M Performance:
-0.47%
6M Performance:
+1.07%
1Y Performance:
-11.75%
1-Day Range:
$18.87
$19.01
1-Week Range:
$18.73
$19.18
52-Week Range:
$14.02
$21.78
Kenvue Inc Stock (KVUE) Company Profile
Name
Kenvue Inc
Sector
Industry
Phone
908-874-1200
Address
1 KENVUE WAY, SUMMIT
Compare KVUE vs PG, UL, CL, KMB
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
18.96 | 36.74B | 15.29B | 1.62B | 1.82B | 0.8433 |
PG
Procter Gamble Co
|
143.33 | 335.60B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
63.52 | 136.04B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
90.17 | 72.44B | 20.80B | 2.22B | 3.77B | 2.5772 |
KMB
Kimberly Clark Corp
|
108.48 | 36.54B | 16.56B | 1.75B | 1.84B | 6.36 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-26 | Downgrade | Jefferies | Buy → Hold |
| Oct-29-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| Sep-26-25 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Apr-10-25 | Initiated | Redburn Atlantic | Neutral |
| Mar-24-25 | Initiated | Evercore ISI | In-line |
| Jan-06-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-12-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Sep-24-24 | Initiated | Jefferies | Buy |
| Sep-24-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-28-24 | Resumed | Citigroup | Neutral |
| Apr-11-24 | Initiated | Bernstein | Underperform |
| Apr-03-24 | Initiated | William Blair | Mkt Perform |
| Mar-01-24 | Resumed | Goldman | Neutral |
| Nov-17-23 | Initiated | Piper Sandler | Neutral |
| Sep-11-23 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-07-23 | Initiated | Canaccord Genuity | Buy |
| Sep-06-23 | Initiated | Argus | Hold |
| Aug-24-23 | Upgrade | Goldman | Neutral → Buy |
| Jul-25-23 | Initiated | Edward Jones | Buy |
| Jun-01-23 | Initiated | HSBC Securities | Hold |
| May-30-23 | Initiated | BofA Securities | Buy |
| May-30-23 | Initiated | Citigroup | Neutral |
| May-30-23 | Initiated | Deutsche Bank | Hold |
| May-30-23 | Initiated | Exane BNP Paribas | Neutral |
| May-30-23 | Initiated | Goldman | Neutral |
| May-30-23 | Initiated | JP Morgan | Overweight |
| May-30-23 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Initiated | UBS | Neutral |
View All
Kenvue Inc Stock (KVUE) Latest News
Essity To Acquire Kenvue’s Brazil Feminine Care Business For $284 Million - Pulse 2.0
Colgate Palmolive India Appoints New CEO - ESM Magazine
Danske Bank A S Purchases New Holdings in Kenvue Inc. $KVUE - MarketBeat
Great Lakes Advisors LLC Makes New $3.52 Million Investment in Kenvue Inc. $KVUE - MarketBeat
253,882 Shares in Kenvue Inc. $KVUE Purchased by Advisors Capital Management LLC - MarketBeat
Colgate-Palmolive India Taps A Kenvue Exec As CEO - Finimize
Kenvue (KVUE) Stock Looks Cheap On Cash Flow But Fair On Earnings - Yahoo Finance
Colgate Palmolive India appoints Kenvue exec as MD and CEO - Business Standard
Colgate Palmolive India appoints Kenvue exec Manish Anandani as MD and CEO - The Economic Times
Essity To Acquire Kenvue’s Brazil Feminine Care Portfolio For $284M - Femtech Insider
Kenvue stock holds around $19 as Brazil feminine care sale and Kimberly-Clark deal reshape outlook - Ad-hoc-news.de
Essity buys Kenvue Brazilian feminine care business in US$284M deal - Personal Care Insights
Essity to Acquire Kenvue's Feminine Care Business in Brazil for $284 Million - paperage.com
Kenvue (KVUE) Stock Looks Reasonable Despite A 37% Fair Value Gap - simplywall.st
Kenvue (KVUE) Launches Zyrtec Spray As Its Undervalued Case Faces A Fresh Test - Yahoo Finance UK
Essity to buy Kenvue’s feminine care brands in Brazil for $284m - Valor International
Kimberly-Clark prepares US$1.9 billion reorganization through synergies following Kenvue acquisition - Tissue Online North America
Tocqueville Asset Management L.P. Makes New $30.30 Million Investment in Kenvue Inc. $KVUE - MarketBeat
Meeder Advisory Services Inc. Makes New $1.17 Million Investment in Kenvue Inc. $KVUE - MarketBeat
Kimberly-Clark stock trades at a discount as Kenvue deal reshapes the outlook - Investing.com
Essity to acquire Kenvue’s feminine care business in Brazil - METissue
Edmond DE Rothschild Holding S.A. Takes Position in Kenvue Inc. $KVUE - MarketBeat
Deutsche Bank AG Makes New Investment in Kenvue Inc. $KVUE - MarketBeat
Neutrogena Parent Stock Takes a Hit Amid Hayden Panettiere Backlash - Complex
Kenvue to Sell Feminine Care Business in Brazil to Essity - marketscreener.com
Essity to buy Kenvue's feminine care business in Brazil for $284 million - marketscreener.com
Kimberly-Clark Looks Undervalued Ahead of Transformative Kenvue Deal, Analysts Say - Investing.com
Kimberly-Clark's purchase of Kenvue sees in-depth China reviewreport - Seeking Alpha
Neutrogena Stock Slips After Outrage Over Hayden Panettiere’s Alleged Firing Following Her Death - Yahoo! Finance Canada
Mitsubishi UFJ Asset Management Co. Ltd. Takes $96.09 Million Position in Kenvue Inc. $KVUE - MarketBeat
Greenland Capital Management LP Takes $3.84 Million Position in Kenvue Inc. $KVUE - MarketBeat
73,621 Shares in Kenvue Inc. $KVUE Bought by Commerzbank Aktiengesellschaft FI - MarketBeat
7,600,073 Shares in Kenvue Inc. $KVUE Bought by Equity Investment Corp - MarketBeat
BlackRock Inc. Purchases Shares of 150,825,694 Kenvue Inc. $KVUE - MarketBeat
Kimberly-Clark/Kenvue: Deal That Would Create Consumer Goods Giant Enters Phase 2 Review in China; SAMR Minister Vacancy Could Figure into Delays on Merger Investigations - The Capitol Forum
Kenvue stock holds steady as dividend yield and Q2 growth support cautious outlook - Ad-hoc-news.de
Zyrtec debuts Allergen Shield Spray, rewrites allergy treatment - Medical Marketing and Media
Neutrogena’s stock spirals after Hayden Panettiere’s tragic death as fans vow to boycott: ‘I will never buy again’ - New York Post
Mondelez Appoints Kenvue Alum Banati CFO - Moomoo
Should Kenvue’s (KVUE) Stronger Q2 2026 Earnings Shift Investors’ View of Its Profitability Story? - Sahm
ZYRTEC® Launches New Drug-Free Allergen Shield Spray, a Breakthrough for Proactive Everyday* Allergen Defense - PR Newswire
Nuance Investments LLC Buys Shares of 1,448,488 Kenvue Inc. $KVUE - MarketBeat
NINE MASTS CAPITAL Ltd Takes $20.26 Million Position in Kenvue Inc. $KVUE - MarketBeat
Plato Investment Management Ltd Invests $1.30 Million in Kenvue Inc. $KVUE - MarketBeat
Kenvue Shares Drop 2.1% While Deal Calculations Account for 88% of Decline in Tylenol Maker - TechStock²
B & T Capital Management DBA Alpha Capital Management Makes New Investment in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. stock falls Monday, underperforms market - MarketWatch
Kenvue’s $1.1 Billion Beauty Segment Faces Scrutiny as Neutrogena Draws Viral Backlash - TechStock²
Kenvue stock holds near analyst targets as income appeal grows - AD HOC NEWS
Wealth Effects LLC Invests $3.38 Million in Kenvue Inc. $KVUE - MarketBeat
87,459 Shares in Kenvue Inc. $KVUE Acquired by HBK Sorce Advisory LLC - MarketBeat
Kenvue Inc Stock (KVUE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.34%
0.98%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):